COMMUNIQUÉS West-GlobeNewswire

Annual General Meeting in ALK-Abelló A/S on 16 March 2026
20/02/2026
The Annual General Meeting of ALK-Abelló A/S (ALKB:DC / Nasdaq Copenhagen: ALK B) will take place on Monday, 16 March 2026 at 4:00 PM (CET) at ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm, Denmark. The agenda of the [...]
CytoDyn Presents Novel CCR5 Inhibition Mechanisms and Long-Term Survival Signals for Leronlimab in Metastatic Breast Cancer at AACR Immuno-Oncology Conference
20/02/2026
Leronlimab-mediated CCR5 blockade modulates T-Cell exhaustion pathways and PD-L1 Biology relevant to ICI response Durable Clinical Observations and Favorable Safety Profile Observed in Heavily Pretreated mTNBC Patients [...]
CDT Acquires Strategic Stake in Sarborg to Transform its AI-Driven Asset Strategy
20/02/2026
NAPLES, Fla. and CAMBRIDGE, United Kingdom, Feb. 20, 2026 (GLOBE NEWSWIRE) -- CDT Equity Inc. (Nasdaq: CDT) (“CDT” or the “Company”), today announced that it has entered into a strategic transaction to acquire a 20% [...]
Mesoblast Financial Results and Corporate Update Webcast
20/02/2026
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss operational highlights and [...]
Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference
20/02/2026
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today [...]
BioStem Technologies to Present at the 46th Annual TD Cowen Healthcare Conference
20/02/2026
POMPANO BEACH, Fla., Feb. 20, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Announces Expanded IP Coverage, Strengthening Position in Biotech Evolution
20/02/2026
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
20/02/2026
DEER PARK, Ill., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare [...]
Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised
20/02/2026
ACTON, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics (NASDAQ: BJDX) today announced that as of February 19, 2026, all of the prefunded warrants issued by the Company in its October 2025 private placement [...]
Biocomposites to launch SYNICEM™ bone cement in UK to ease supply crisis
20/02/2026
Biocomposites responds to NHS supply crisis by bringing forward launch of its SYNICEM™ bone cement products in the UK Over 500,000 SYNICEM™ bone cement packs are already used by surgeons globally every year to help [...]
RAMSAY SANTE : Nouvelle étape pour Ramsay Santé, dans le cadre du projet de distribution par Ramsay Health Care à ses actionnaires de sa participation dans Ramsay Santé
20/02/2026
COMMUNIQUÉ DE PRESSE Paris, le 20 février 2026 Nouvelle étape pour Ramsay Santé, dans le cadre du projet de distribution par Ramsay Health Care à ses actionnaires de sa participation dans Ramsay Santé Ramsay Générale de [...]
O3R-5671 Pharmacokinetic and Pharmacodynamic Data to be Presented at ECCO and Dosing in Final Cohort in First-in-human study initiated
20/02/2026
Data from the first in human study on O3R-5671’s potent TNFα inhibition Studies in ulcerative colitis and psoriasis to initiate in H2 2026 Leuven, Belgium. February 20, 2025 . Onco3R Therapeutics, a clinical-stage [...]
PL BioScience Signs Exclusive Japanese Distribution Agreement with Summit Pharmaceuticals International
20/02/2026
Summit Pharmaceuticals International Corp. to serve as exclusive distributor for cell culture supplements in Japanese Market. The agreement marks PL BioScience’s first exclusive distribution partnership in Japan. Cell [...]
RAMSAY SANTE : New step for Ramsay Santé in connection with Ramsay Health Care's proposal to distribute its shareholding in Ramsay Santé to its shareholders
20/02/2026
PRESS RELEASE Paris, 20 February 2026 New step for Ramsay Santé in connection with Ramsay Health Care's proposal to distribute its shareholding in Ramsay Santé to its shareholders Ramsay Générale de Santé (“ Ramsay [...]
FDA accepts New Drug Application for Roche’s giredestrant in ESR1-mutated, ER-positive advanced breast cancer
20/02/2026
Filing acceptance based on phase III data showing giredestrant plus everolimus reduced the risk of disease progression or death by 44% and 62% in ITT and ESR1 -mutated populations, respectively, versus standard-of-care [...]
Henriette Mersebach to step down as ALK’s head of R&D
20/02/2026
ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced that Henriette Mersebach will step down as Executive Vice President, Research and Development, and as a member of the Board of Management, effective 23 February [...]
YWECARE Expands Across Australia as Demand Grows for Transparent and Accountable NDIS Providers
20/02/2026
YWECARE Emerges as One of Australia’s Fast-Growing NDIS Providers Sydney, NSW, Feb. 20, 2026 (GLOBE NEWSWIRE) -- In an industry often under supervision for inconsistency and compliance failures, an NDIS PROVIDER is [...]
Annual report 2025: ALK delivers 15% revenue growth and 26% EBIT margin
20/02/2026
ALK’s (ALKB:DC / Nasdaq Copenhagen: ALK B) full-year results came in at the top end of the latest outlook, supported by solid performance in Q4 and continued commercial momentum. ALK expects sustained high organic [...]
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
20/02/2026
MELBOURNE, Australia and INDIANAPOLIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the year ended December 31, 2025. FY 2025 [...]

Pages